Candel Therapeutics, Inc. CADL Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s other income (expense)?
- Candel Therapeutics, Inc. (CADL) reported other income (expense) of $7.42M in Q1 2026.
- How has Candel Therapeutics, Inc.'s other income (expense) changed year-over-year?
- Candel Therapeutics, Inc.'s other income (expense) decreased by 52.1% year-over-year, from $15.51M to $7.42M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.